ProfileGDS4718 / 1554129_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 51% 48% 51% 49% 52% 50% 57% 54% 49% 49% 48% 54% 49% 51% 43% 45% 55% 54% 59% 55% 50% 45% 46% 49% 49% 50% 51% 49% 55% 54% 50% 54% 53% 48% 50% 54% 52% 50% 45% 47% 55% 54% 50% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7498854
GSM549102patient 115, normal, homogenized [OPG study]5.5982851
GSM549104patient 119, normal, homogenized [OPG study]5.4006448
GSM549108patient 138, normal, homogenized [OPG study]5.617351
GSM549119patient 077, normal, homogenized [OPG study]5.494749
GSM549133patient 032, cancer, homogenized [OPG study]5.5672452
GSM549139patient 042, cancer, homogenized [OPG study]5.5231450
GSM549099patient 107, normal, homogenized [OPG study]5.9118357
GSM549109patient 139, normal, homogenized [OPG study]5.7594154
GSM549110patient 046, normal, homogenized [OPG study]5.4539949
GSM549114patient 063, normal, homogenized [OPG study]5.4331549
GSM549122patient 082, normal, homogenized [OPG study]5.390348
GSM549134patient 033, cancer, homogenized [OPG study]5.7445554
GSM549136patient 036, cancer, homogenized [OPG study]5.3788849
GSM549140patient 044, cancer, homogenized [OPG study]5.539251
GSM549111patient 047, normal, homogenized [OPG study]5.1348343
GSM549113patient 057, normal, homogenized [OPG study]5.1978345
GSM549132patient 031, cancer, homogenized [OPG study]5.7938455
GSM549137patient 038, cancer, homogenized [OPG study]5.7378954
GSM549142patient 047, cancer, homogenized [OPG study]6.1620259
GSM549100patient 110, normal, homogenized [OPG study]5.7819955
GSM549107patient 135, normal, homogenized [OPG study]5.4646750
GSM549115patient 068, normal, homogenized [OPG study]5.1639445
GSM549116patient 072, normal, homogenized [OPG study]5.271846
GSM549120patient 078, normal, homogenized [OPG study]5.447349
GSM549131patient 030, cancer, homogenized [OPG study]5.4276249
GSM549118patient 074, normal, homogenized [OPG study]5.526550
GSM549129patient 027, cancer, homogenized [OPG study]5.6164451
GSM549123patient 088, normal, homogenized [OPG study]5.4171549
GSM549124patient 006, cancer, homogenized [OPG study]5.8313655
GSM549126patient 015, cancer, homogenized [OPG study]5.7326154
GSM549128patient 025, cancer, homogenized [OPG study]5.5028850
GSM549103patient 117, normal, homogenized [OPG study]5.8022654
GSM549117patient 073, normal, homogenized [OPG study]5.6206853
GSM549138patient 041, cancer, homogenized [OPG study]5.3783448
GSM549141patient 045, cancer, homogenized [OPG study]5.4797150
GSM549130patient 028, cancer, homogenized [OPG study]5.716454
GSM549101patient 111, normal, homogenized [OPG study]5.6777652
GSM549105patient 128, normal, homogenized [OPG study]5.5114550
GSM549106patient 134, normal, homogenized [OPG study]5.1717745
GSM549112patient 048, normal, homogenized [OPG study]5.3323747
GSM549125patient 011, cancer, homogenized [OPG study]5.8358355
GSM549127patient 024, cancer, homogenized [OPG study]5.7426654
GSM549135patient 035, cancer, homogenized [OPG study]5.4848550